Cytokinetics, Incorporated (CYTK)
NASDAQ·Healthcare·Biotechnology
$70.26
+1.42%
Mkt Cap $8.52B
Analyst Ratings
Buy
23
Hold
1
Sell
0
Price Target (43 analysts)
$92.50
Range $69.00 – $136.00
Implied Upside
+31.7%
Consensus $92.50 vs current $70.26
NASDAQ·Healthcare·Biotechnology
$70.26
+1.42%
Mkt Cap $8.52B
Buy
23
Hold
1
Sell
0
Price Target (43 analysts)
$92.50
Range $69.00 – $136.00
+31.7%
Consensus $92.50 vs current $70.26